McGill University is home to world-renowned research initiatives focusing on rare diseases, particularly through The Montreal Neurological Institute and Hospital (The Neuro). The Rare Neurological Diseases Group at The Neuro prioritizes advancing research and clinical care for conditions like amyotrophic lateral sclerosis (ALS) and Autosomal Recessive Spastic Ataxia of Charlevoix-Saguenay (ARSACS). They focus on developing new diagnostic methods, innovative treatments, and improving the overall understanding of rare neurological conditions. McGill’s multidisciplinary collaborations ensure that their findings have both local and global impacts.

Medlior Assistant